Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,518.9
-11.4 (-0.45%)

 

  • STI Straits Times Index
    2,518.9
    -11.4 (-0.45%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,449.0
    12.2 (0.85%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,301.4
    -83.3 (-0.36%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,836.8
    -9.7 (-0.34%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,419.2
    148.1 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,641.6
    14.8 (0.32%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,221.7M
  • Value: 1,172.2M
  • Rise: 157
  • Fall: 140
  • Unch: 511

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Reenova Investment^0.003+0.001
Medtecs Intl0.235+0.045
Rex Intl0.144-
UG Healthcare0.455+0.085
Clearbridge0.205+0.021
Singapore-eDev0.056+0.003
ComfortDelGro1.530-
Genting Sing0.780+0.020
Singtel2.620-0.040
Golden Agri-Res0.150+0.003

World Indices

World Indices
Name Last Change
Nasdaq 9,340.2 +15.6
HSI 23,301.4 -83.3
HSCEI 9,567.4 -27.8
Jakarta 4,641.6 +14.8
Nikkei 225 21,419.2 +148.1
SSE Comp 2,836.8 -9.7
Shanghai A 2,973.3 -10.2
Shanghai B 207.0 -1.1
KOSPI 2,031.2 +1.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ACCELERON PHARMA ACCELERON PHARMA
Updated on 26 May 2020 (End of trading day)
Last (USD): 98.420 Change: -0.170 High: 102.440 Remarks: -
Change (%): -0.17 Low: 98.210
Open 101.120 Yesterday's Close 98.59
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 408,908 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.31972 Trailing EPS (USD) e -2.55915 NAV (USD) b 7.6883
PE a - Trailing PE f - Price / NAV b 12.8013
Dividend (USD) d - Cash In Hand (USD) g 5.1554 Issued & Paid-up Shares c 53,824,600
Dividend Yield (%) d - Price / Cash In Hand g 19.091 Treasury Shares h -
Beta - 75 Daysi 0.996 R-Squared - 75 Days(%)i 59.77 Market Cap (M) 5,297.417
Beta - 500 Daysi 0.750 R-Squared - 500 Days (%)i 9.04 Enterprise Value (M) 4,907.895
Piotroski F Score 1 Exchange Code XLRN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 71.76 Free Float (%) 85.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ACCELERON PHARMA NASDAQ 5,297.417 - - 12.8013 -
Industry Biotechnology NASDAQ 2,715.539 354.285 68678.556 6.6771 0.706
Local Peer AMGEN INC NASDAQ 130,826.133 16.683 17.046 13.7929 2.622
Local Peer GILEAD SCIENCES INC NASDAQ 91,767.720 17.038 18.494 4.1586 3.477
Local Peer VERTEX PHARMACEUTICAL NASDAQ 69,097.321 58.716 45.732 10.6934 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,348.103 28.995 26.915 5.0563 -
Local Peer ILLUMINA INC NASDAQ 52,098.270 51.994 55.306 11.2402 -
Local Peer BIOGEN INC NASDAQ 48,282.138 8.199 8.213 3.8481 -
Local Peer SEATTLE GENETICS INC NASDAQ 26,264.766 - - 14.8756 -
Local Peer MODERNA INC NASDAQ 21,423.337 - - 13.0560 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,701.016 9.442 9.562 1.9324 -
Local Peer INCYTE CORPORATION NASDAQ 21,450.368 47.998 - 11.0699 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 18,760.030 - 164.553 5.7902 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 15,426.413 - - 11.4293 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), UNIQURE N.V. (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), NOVAVAX INC (NASDAQ), ALECTOR INC (NASDAQ), INSMED INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), EPIZYME INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), REGENXBIO INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VERACYTE INC (NASDAQ), MACROGENICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COMPUGEN (NASDAQ), PASSAGE BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), RETROPHIN INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ARDELYX INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AVROBIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), NANTKWEST INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROTHENA CORP PLC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MERUS B V (NASDAQ), PRECIGEN INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), XBIOTECH INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), PERSONALIS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PDL BIOPHARMA INC (NASDAQ), KAMADA (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CHIASMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), XOMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AFFIMED N V (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), VAXART INC (NASDAQ), INFLARX N V (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), IVERIC BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), ARAVIVE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), LUMOS PHARMA INC (NASDAQ), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), RESTORBIO INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), SYNLOGIC INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), VACCINEX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), EQUILLIUM INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), ZAFGEN INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), TOCAGEN INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CURIS INC (NASDAQ), EVOGENE LTD (NASDAQ), BIOCARDIA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PRECIPIO INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 139,679.094 52.062 48.219 16.1508 0.862
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 26,670.241 24.902 39.049 5.5936 0.760
Global Peer WUXI BIO HKEx 160,318.674 139.460 139.460 11.2107 -
Global Peer SINO BIOPHARM HKEx 149,533.718 48.719 48.720 4.2968 0.670
Global Peer BEIGENE HKEx 97,546.323 - - 4.4752 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,404.459 80.816 64.676 4.0979 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 31,747.829 - - 10.6440 -
Global Peer 3SBIO HKEx 22,795.730 20.646 20.646 2.1173 -
Other Global Peers ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), VIVA BIOTECH (HKEx), MESOBLAST LTD (ASX), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), LEE'S PHARM (HKEx), DPHARMA (Bursa), BBI LIFE SCI (HKEx), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), CEL-SCI CORP (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), UNI-BIO GROUP (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), IMUGENE LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), BIOTRON (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), MEMPHASYS LTD (ASX), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES (ASX), Suntar Eco-City^ (SGX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIONOMICS LTD (ASX), REGENT PACIFIC (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), SIENNA CANCER DIAGNOSTICS LTD (ASX), REGENEUS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HAO WEN HLDGS (HKEx), AMPLIA THERAPEUTICS LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), CRYOSITE (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --4.310
-4.20 %
10 Days --1.290
-1.29 %
20 Days -+5.500
+5.92 %
Medium Term Return 3 Months -+11.060
+12.66 %
6 Months -+49.970
+103.14 %
1 Year -+57.090
+138.13 %
Long Term Return 2 Years -+62.290
+172.41 %
3 Years -+72.910
+285.81 %
5 Years -+66.200
+205.46 %
Annualised Return Annualised --
+25.02 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 37.010 - 108.500 Change From 1 Year Low +61.410 % Change From 1 Year Low (%) +165.93
Change From 1 Year High -10.080 % Change From 1 Year High (%) -9.29
2 Years Range 32.530 - 108.500 Change From 2 Years Low +65.890 % Change From 2 Years Low (%) +202.55
Change From 2 Years High -10.080 % Change From 2 Years High (%) -9.29
5 Years Range 20.000 - 108.500 Change From 5 Years Low +78.420 % Change From 5 Years Low (%) +392.10
Change From 5 Years High -10.080 % Change From 5 Years High (%) -9.29
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
26 May 2020 101.120 102.440 98.210 98.420 408,908 -
22 May 2020 99.160 99.160 96.770 98.590 200,416 -
21 May 2020 103.100 103.100 97.390 99.090 205,440 -
20 May 2020 101.000 103.000 99.870 102.730 337,884 -
19 May 2020 104.330 107.700 99.060 99.760 358,581 -
18 May 2020 105.000 107.710 103.800 104.600 712,504 -
15 May 2020 97.910 102.480 96.030 102.110 287,733 -
14 May 2020 97.140 99.490 95.790 98.010 401,274 -
13 May 2020 99.960 102.580 96.400 99.710 406,548 -
12 May 2020 107.000 108.500 100.510 100.705 566,803 -
11 May 2020 99.830 107.670 99.830 105.100 586,483 -
08 May 2020 104.960 104.970 100.460 101.790 240,127 -
07 May 2020 102.620 105.220 101.550 103.000 275,550 -
06 May 2020 100.170 103.060 98.935 101.260 487,753 -
05 May 2020 98.000 101.500 97.350 99.220 300,171 -
04 May 2020 88.880 97.190 87.590 97.000 531,264 -
01 May 2020 89.530 90.560 85.320 88.720 476,137 -
30 Apr 2020 92.170 93.660 89.560 90.530 304,278 -
29 Apr 2020 96.320 96.320 91.835 92.920 283,802 -
28 Apr 2020 100.640 101.080 93.910 94.360 253,875 -
27 Apr 2020 100.000 101.490 98.580 99.550 299,420 -
24 Apr 2020 94.990 99.760 94.990 99.500 271,562 -
Summary
Current 2 Weeks
(12 May 2020 to 26 May 2020)
107.000 108.500 95.790 98.420 3,886,091 -
Previous 2 Weeks
(28 Apr 2020 to 11 May 2020)
100.640 108.500 93.910 105.100 3,739,440 -
4 Weeks from
(30 Mar 2020 to 27 Apr 2020)
87.130 108.500 83.520 99.550 9,687,736 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.